11-108510085-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_015065.3(EXPH5):c.5422C>T(p.Arg1808Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000639 in 1,611,770 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000068 ( 0 hom. )
Consequence
EXPH5
NM_015065.3 stop_gained
NM_015065.3 stop_gained
Scores
2
5
Clinical Significance
Conservation
PhyloP100: -0.634
Genes affected
EXPH5 (HGNC:30578): (exophilin 5) The protein encoded by this gene is a member of the synaptotagmin-like protein (Slp) family lacking a C2 domain. It contains an N-terminal synaptotagmin-like homology domain (SHD), and is a ras-related protein Rab-27B effector protein. This protein is thought to be involved in exosome secretion and intracellular vesicle trafficking. Reduced expression of this gene results in keratin filament defects. Mutations in this gene have been associated with some cases of epidermolysis bullosa, an inherited skin fragility disorder. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PVS1
?
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0918 CDS is truncated, and there are 2 pathogenic variants in the truncated region.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 11-108510085-G-A is Pathogenic according to our data. Variant chr11-108510085-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1805039.We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=1, Uncertain_significance=1}. Variant chr11-108510085-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EXPH5 | NM_015065.3 | c.5422C>T | p.Arg1808Ter | stop_gained | 6/6 | ENST00000265843.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EXPH5 | ENST00000265843.9 | c.5422C>T | p.Arg1808Ter | stop_gained | 6/6 | 1 | NM_015065.3 | P4 | |
EXPH5 | ENST00000525344.5 | c.5401C>T | p.Arg1801Ter | stop_gained | 7/7 | 1 | A2 | ||
EXPH5 | ENST00000526312.5 | c.5194C>T | p.Arg1732Ter | stop_gained | 6/6 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
4
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000562 AC: 14AN: 249014Hom.: 0 AF XY: 0.0000446 AC XY: 6AN XY: 134594
GnomAD3 exomes
AF:
AC:
14
AN:
249014
Hom.:
AF XY:
AC XY:
6
AN XY:
134594
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000678 AC: 99AN: 1459602Hom.: 0 Cov.: 33 AF XY: 0.0000757 AC XY: 55AN XY: 726076
GnomAD4 exome
AF:
AC:
99
AN:
1459602
Hom.:
Cov.:
33
AF XY:
AC XY:
55
AN XY:
726076
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74330
GnomAD4 genome
?
AF:
AC:
4
AN:
152168
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
?
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 06, 2021 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a reported mechanism of disease in this gene and is associated with autosomal recessive nonspecific epidermolysis bullosa (MIM#615028; PMID: 27730671). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0205 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with less than 1/3 of the protein sequence affected. (SP) 0252 - This variant is homozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2: 14 heterozygotes, 0 homozygotes). (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0703 - Other variants predicted to result in a truncated protein comparable to the one identified in this case have moderate previous evidence for pathogenicity. Two truncations downstream have been reported. p.(Pro1929Leufs*8) has been found in two families with recessive epidermolysis bullosa (PMIDs: 23176819, 32176379) and is also reported pathogenic in ClinVar, and p.(Phe1897Serfs*2) has been reported in an individual with fragile skin among other features such as intellectual disability (LOVD). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an individual. It was identified in a consanguineous family, in a homozygous individual who was also homozygous for p.(Thr68LeufsTer106) in the COL17A1 gene and presented with a complex blended phenotype (EB simplex and junctional EB) explained by both genes (PMID: 30016581). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1010 - Functional evidence for this variant is inconclusive. Immunofluorescence staining showed no Exph5 protein in skin, however, the antibodies used were targeting the C-terminal, which is expected to be deleted in this truncated protein that is not predicted to result in nonsense mediated decay (PMID: 30016581). (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Feb 10, 2022 | This sequence change creates a premature translational stop signal (p.Arg1808*) in the EXPH5 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 182 amino acid(s) of the EXPH5 protein. This variant is present in population databases (rs142805294, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with clinical features of EXPH5-related conditions (PMID: 28830826). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
Cadd
Pathogenic
Dann
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
D;D;D;D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at